Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.10USD
16 Nov 2018
Change (% chg)

$0.05 (+4.76%)
Prev Close
$1.05
Open
$1.06
Day's High
$1.10
Day's Low
$1.06
Volume
5,412
Avg. Vol
18,235
52-wk High
$2.25
52-wk Low
$1.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.177
Jun '18 0.00 -0.159
Mar '18 0.00 -0.117
FY 2017 Dec '17 0.00 -0.175
Sep '17 0.00 -0.907
Jun '17 0.00 -0.504
Mar '17 0.00 -0.376
FY 2016 Dec '16 0.28 -0.678
Sep '16 0.20 -0.862
Jun '16 0.22 -1.005
Mar '16 0.14 -1.042
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.67 2.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 3 -0.17 -0.13 -0.21 --
Quarter Ending Mar-19 2 -0.19 -0.16 -0.22 --
Year Ending Dec-18 3 -0.63 -0.58 -0.67 --
Year Ending Dec-19 3 -0.69 -0.58 -0.82 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 79.36 29.34
P/E High - Last 5 Yrs. -- 265.87 45.80
P/E Low - Last 5 Yrs. -- 84.08 25.31
Beta 3.30 0.73 0.91
Price to Sales (TTM) -- 217.51 20.58
Price to Book (MRQ) 0.77 16.40 4.23
Price to Tangible Book (MRQ) 0.77 20.76 12.86
Price to Cash Flow (TTM) -- 48.38 21.19
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.65
Dividend Yield - 5 Year Avg -- 0.23 1.43
Dividend 5 Year Growth Rate -- 3.73 -8.12
Payout Ratio(TTM) -- 7.92 43.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 147.95 6.76
Sales (TTM) vs TTM 1 Yr. Ago -100.00 61.16 5.37
Sales - 5 Yr. Growth Rate -- 22.11 7.50
EPS (MRQ) vs Qtr. 1 Yr. Ago 68.57 79.14 28.07
EPS (TTM) vs TTM 1 Yr. Ago 43.95 -- --
EPS - 5 Yr. Growth Rate -- 20.47 7.61
Capital Spending - 5 Yr. Growth Rate 1.61 34.50 8.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.42 2.60
Current Ratio (MRQ) 5.68 6.52 3.62
LT Debt to Equity (MRQ) 0.00 18.23 9.93
Total Debt to Equity (MRQ) 0.00 24.16 13.84
Interest Coverage (TTM) -268.82 -167.48 35.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.41 53.45
Gross Margin - 5 Yr. Avg. -- 47.56 52.35
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,420.21 -157.21 16.19
Operating Margin (TTM) -- -1,764.99 -12.21
Operating Margin - 5 Yr. Avg. -1,431.26 -170.35 11.73
Pre-Tax Margin (TTM) -- -1,697.68 -10.76
Pre-Tax Margin - 5 Yr. Avg. -1,306.91 -173.02 12.03
Net Profit Margin (TTM) -- -1,693.54 -14.16
Net Profit Margin - 5 Yr. Avg. -1,127.90 -173.38 8.29
Effective Tax Rate (TTM) -- 14.72 21.78
Effective Tax Rate - 5 Yr. Avg. -- 19.72 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,455,811 843,940,439
Net Income/Employee (TTM) -577,417 -3,607,800 98,316,310
Receivable Turnover (TTM) -- 8.35 5.42
Inventory Turnover (TTM) -- 2.90 4.00
Asset Turnover (TTM) 0.00 0.48 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.70 -0.72 10.84
Return on Assets - 5 Yr. Avg. -47.89 2.40 11.60
Return on Investment (TTM) -45.44 -0.30 13.58
Return on Investment - 5 Yr. Avg. -63.52 2.31 14.86
Return on Equity (TTM) -94.54 -2.98 15.11
Return on Equity - 5 Yr. Avg. -81.57 -1.50 16.02
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 44.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cyclacel Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.09%
# of Holders: 2
Total Shares Held: 3,645
3 Mo. Net Change: -13,253
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.